Haemonetics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar 2025Mar 2024Apr 2023Apr 2022Apr 2021
Valuation Ratios
P/E Ratio18.9336.8736.1775.2471.65
Forward P/E13.2120.4925.4523.8233.88
P/S Ratio2.333.313.573.296.54
P/B Ratio3.874.515.104.367.78
Price/Tangible Book54.93
Price/FCF22.2930.1851.0843.0879.34
Price/OCF17.4723.8515.2918.9552.33
PEG Ratio1.001.392.421.362.46
Enterprise Value Ratios
EV/Revenue3.053.834.043.836.69
EV/EBITDA11.6416.9618.7219.8731.60
EV/EBIT16.7824.2328.2136.2258.21
EV/FCF29.1034.8957.7150.2881.19
Profitability & Returns
Return on Equity (ROE)0.19%0.13%0.15%0.06%0.12%
Return on Assets (ROA)0.07%0.06%0.06%0.04%0.04%
Return on Invested Capital (ROIC)0.11%0.11%0.10%0.05%0.09%
Return on Capital Employed (ROCE)0.13%0.11%0.10%0.07%0.06%
Leverage & Solvency Ratios
Debt/Equity1.560.911.021.121.08
Debt/EBITDA3.492.863.284.144.02
Debt/FCF9.016.0810.1611.0710.98
Liquidity Ratios
Current Ratio1.622.563.061.712.74
Quick Ratio0.881.291.840.951.26
Efficiency Ratios
Asset Turnover0.590.630.620.540.56
Inventory Turnover1.712.071.981.501.49
Yield & Distribution Ratios
Earnings Yield0.05%0.03%0.03%0.01%0.01%
FCF Yield0.04%0.03%0.02%0.02%0.01%
Buyback Yield0.01%0.00%0.00%0.00%0.01%